Investing Business News
  • Politics
  • Business
  • Investing
  • Stock
No Result
View All Result
  • Politics
  • Business
  • Investing
  • Stock
No Result
View All Result
Investing Business News
No Result
View All Result
Home Politics

CDC official includes ‘pregnant people’ terminology and pronouns in resignation letter

August 29, 2025
in Politics
CDC official includes ‘pregnant people’ terminology and pronouns in resignation letter

A Centers for Disease Control and Prevention official who posted his resignation letter on social media used the term ‘pregnant people’ and capped off his missive by including ‘he/his/him’ pronouns after his name.

‘I am writing to formally resign from my position as Director of the National Center for Immunization and Respiratory Diseases at the Centers for Disease Control and Prevention (CDC), effective August 28, 2025, close of business,’ Dr. Demetre Daskalakis wrote in the lengthy post on X.

Daskalakis accused President Donald Trump’s administration of attempting ‘to erase transgender populations.’

‘For decades, I have been a trusted voice for the LGBTQ community when it comes to critical health topics. I must also cite the recklessness of the administration in their efforts to erase transgender populations, cease critical domestic and international HIV programming, and terminate key research to support equity as part of my decision,’ he wrote.

The inclusion of pronouns and the term ‘pregnant people’ caught people’s attention.

‘This resignation is a huge win for the Trump administration and the American people. We don’t need anyone who can’t understand basic biology working at the CDC,’ noted Jeremy Redfern, communications director for Florida Attorney General James Uthmeier.

Karol Markowicz tweeted, ‘No one who uses ‘pregnant people’ should work at the CDC. This isn’t hard.’ 

Responding to Markowicz’s post, Florida Gov. Ron DeSantis wrote, ‘Example of how ‘trusting the science’ really means following the political science and perpetuating the prevailing narrative…’ He added, ‘Embracing evidence-based medicine should be the bare minimum for working at the CDC…’

Daskalakis suggested that the Department of Health and Human Services is on a ‘dangerous’ path.

‘I am unable to serve in an environment that treats CDC as a tool to generate policies and materials that do not reflect scientific reality and are designed to hurt rather than to improve the public’s health,’ he wrote.

‘I wish the CDC continued success in its vital mission and that HHS reverse its dangerous course to dismantle public health as a practice and as an institution. If they continue the current path, they risk our personal well-being and the security of the United States,’ Daskalakis concluded at the end of his message.

Fox News Digital reached out to HHS for comment on Thursday.

This post appeared first on FOX NEWS

Previous Post

Appendix 4E

Next Post

Eli Lilly joins forces with China tech giant to expand obesity drug market

    Sign up for our newsletter to receive the latest insights, updates, and exclusive content straight to your inbox! Whether it's industry news, expert advice, or inspiring stories, we bring you valuable information that you won't find anywhere else. Stay connected with us!


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Recent News

    XRP price jumps 3% amid SEC ETF approval, upcoming US fund launch

    XRP price jumps 3% amid SEC ETF approval, upcoming US fund launch

    September 18, 2025
    Asian markets end mixed: CSI 300 slips over 1%, Nikkei hits new high

    Asian markets end mixed: CSI 300 slips over 1%, Nikkei hits new high

    September 18, 2025
    September 2025
    M T W T F S S
    1234567
    891011121314
    15161718192021
    22232425262728
    2930  
    « Aug    
    • About us
    • Contact us
    • Privacy Policy
    • Terms & Conditions

    Copyright © 2025 investingbusinessnews.com | All Rights Reserved

    No Result
    View All Result
    • About us
    • Contact us
    • Home 1
    • Privacy Policy
    • Terms & Conditions
    • Thank you

    Copyright © 2025 investingbusinessnews.com | All Rights Reserved